Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Price:
8.61
USD
Market Closed
Market Cap:
$391.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
US |
|
N
|
Northrop Grumman Corp
F:NTH
|
US |
|
Cisarua Mountain Dairy Tbk PT
IDX:CMRY
|
ID |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YMAB's stock price target?
Not Available
YMAB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Y-mAbs Therapeutics Inc?
Projected CAGR
8%
8%
The compound annual growth rate for Revenue over the next 3 years is 8%.
